The Nasdaq announced Monday that Moderna will be added to its Nasdaq 100 index in July. Moderna’s shares rose as much as 18% on Monday. On Monday, Jefferies kicked off Moderna’s coverage with a “buy” rating and a target price of $ 90 over the approval potential of the pharmaceutical …
Read More »
Text size Maddie Meyer / Getty Images Moderna’s shares have risen 239% so far this year, and the biotech company, which has no approved medications, has a market capitalization of more than $ 24 billion. But in a note sent out Monday morning, Jefferies analyst Michael Yee writes that the …
Read More »
Text size Joseph Prezioso / Getty Images Shares of Modern biotechnology fell 6.2% on Thursday afternoon after health news website Stat reported that the company was delaying the start of a Phase 3 trial of its experimental Covid-19 vaccine. The report, based on quotes from unidentified sources described as “investigators,” …
Read More »
The Food and Drug Administration (FDA) issued new rules Tuesday for companies developing COVID-19 vaccines. “While the FDA is committed to helping expedite this work, we are not going to cut corners in our decision making, and we are clarifying in our guidance what data we need, which needs to …
Read More »
Text size Joseph Prezioso / AFP via Getty Images Moderna said it has partnered with Catalent to make the Covid-19 vaccine that the biotech company is about to test in the country’s first major clinical trial. Although the vaccine’s large-scale safety and efficacy have not yet been proven, the urgency …
Read More »